openPR Logo
Press release

Viral Vector Manufacturing Market worth $3,590.97 million by 2030, growing at a CAGR of 19.04% - Exclusive Report by 360iResearch

10-20-2023 12:43 PM CET | Health & Medicine

Press release from: 360iResearch

Viral Vector Manufacturing Market | 360iResearch

Viral Vector Manufacturing Market | 360iResearch

The "Viral Vector Manufacturing Market by Type (Adeno-associated Viral Vectors, Adenoviral Vectors, Lentiviral Vectors), Disease (Cancer, Genetic Disorders, Infectious Diseases), Application - Global Forecast 2023-2030" report has been added to 360iResearch.com's offering.

Request Sample Copy of this Report @ https://www.360iresearch.com/library/intelligence/viral-vector-manufacturing?utm_source=openpr&utm_medium=referral&utm_campaign=sample

Market Segmentation & Coverage:

This research report categorizes the Viral Vector Manufacturing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Adeno-associated Viral Vectors, Adenoviral Vectors, Lentiviral Vectors, and Retroviral Vectors. The Retroviral Vectors is projected to witness significant market share during forecast period.

Based on Disease, market is studied across Cancer, Genetic Disorders, and Infectious Diseases. The Genetic Disorders is projected to witness significant market share during forecast period.

Based on Application, market is studied across Gene Therapy and Vaccinology. The Vaccinology is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Viral Vector Manufacturing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the Viral Vector Manufacturing Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the Viral Vector Manufacturing Market, highlighting leading vendors and their innovative profiles. These include ABL Inc., Beckman Coulter, Inc., Biovian Oy, Charles River Laboratories International, Inc., Cytiva, Finvector, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., Genezen Laboratories, Inc., Lonza Group Ltd., Merck KGaA, Novartis AG, Sanofi SA, Spark Therapeutics, Inc. by F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., and uniQure N.V..

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Viral Vector Manufacturing Market, by Type
7. Viral Vector Manufacturing Market, by Disease
8. Viral Vector Manufacturing Market, by Application
9. Americas Viral Vector Manufacturing Market
10. Asia-Pacific Viral Vector Manufacturing Market
11. Europe, Middle East & Africa Viral Vector Manufacturing Market
12. Competitive Landscape
13. Competitive Portfolio
14. Appendix

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Viral Vector Manufacturing Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Viral Vector Manufacturing Market?
3. What is the competitive strategic window for opportunities in the Viral Vector Manufacturing Market?
4. What are the technology trends and regulatory frameworks in the Viral Vector Manufacturing Market?
5. What is the market share of the leading vendors in the Viral Vector Manufacturing Market?
6. What modes and strategic moves are considered suitable for entering the Viral Vector Manufacturing Market?

Read More @ https://www.360iresearch.com/library/intelligence/viral-vector-manufacturing?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Viral Vector Manufacturing Market worth $3,590.97 million by 2030, growing at a CAGR of 19.04% - Exclusive Report by 360iResearch here

News-ID: 3258332 • Views:

More Releases from 360iResearch

Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Global Treatment Demand
Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and expected to reach USD 10.06 billion in 2024, at a CAGR 7.63% to reach USD 15.71 billion by 2030.
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 2023 and expected to reach USD 292.84 billion in 2024, at a CAGR 11.08% to reach USD 552.63 billion by 2030.
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 and expected to reach USD 62.23 billion in 2024, at a CAGR 9.99% to reach USD 110.34 billion by 2030.
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital

All 5 Releases


More Releases for Vector

Growing Prevalence Of Vector-Borne Diseases Fuels Vector Control Market: Pivotal …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. Vector Control Market Size Growth Forecast: What to Expect by 2025? The market size of vector control has been experiencing robust growth in the past years, and it's predicted to increase from $20.53 billion in 2024 to $22.01 billion in 2025, with a compound annual growth rate (CAGR) of 7.2%. Factors such as urbanization
Global Viral Vector Manufacturing Market Size by Application, Type, and Geograph …
USA, New Jersey- According to Market Research Intellect, the global Viral Vector Manufacturing market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period. The viral vector manufacturing market is witnessing accelerated growth due to the rising demand for gene therapies and vaccines. These vectors are essential tools
Prominent Viral Vector Manufacturing Market Trend for 2025: Product Innovation I …
How Are the key drivers contributing to the expansion of the viral vector manufacturing market? The escalation in the occurrence of both cancer and contagious diseases is anticipated to spur the expansion of the viral vector manufacturing market in the future. An infectious disease is a condition caused by a virus or its harmful byproduct which spreads to a susceptible organism through contact with an infected individual, creature, or object. Cancer
Emerging Lentiviral Vector Market Trend 2025-2034: Technological Advancements In …
How Is the Lentiviral Vector Market Projected to Grow, and What Is Its Market Size? The lentiviral vector market will grow from $14.37 billion in 2024 to $16.62 billion in 2025, at a CAGR of 15.7%. This market is expanding due to the growing prevalence of genetic disorders, increasing demand for gene delivery systems, biotech and pharmaceutical investments, and regulatory approvals for related therapies. The lentiviral vector market is expected to grow
Viral Vector Manufacturing Market Report 2024 - Viral Vector Manufacturing Marke …
"The Business Research Company recently released a comprehensive report on the Global Viral Vector Manufacturing Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive
Adeno-Associated Virus Vector Manufacturing Market - Building Better Therapies: …
Newark, New Castle, USA - Growth Plus Reports has published a new report on Adeno-Associated Virus Vector Manufacturing Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Adeno-Associated Virus Vector Manufacturing provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and